Comparing Buprenorphine pill vs injection for opioid use disorder
Part of Mental health clinical trials.
This study compares two forms of a medication called buprenorphine (one is a pill you take under the tongue, the other is an injection) to see which works better for treating opioid use disorder. If you are eligible, you will receive one of these forms for a year and regular check-ups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have used opioids in the last 30 days
- You are diagnosed with moderate to severe opioid use disorder
- You are willing to start treatment with buprenorphine (a medication that helps reduce cravings)
- If you are a person who could become pregnant, you must not be pregnant or breastfeeding and must use birth control
- You do not have serious kidney problems or need dialysis
- You do not have severe COVID-19 symptoms that could put you at risk
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two medications, methadone and buprenorphine, to see which helps people stay in treatment for opioid use disorder. You may be eligible if you are starting a new treatment episode.
This study tests two different forms of buprenorphine (a medication for opioid addiction) to see which works better for people who use fentanyl or other strong synthetic opioids. If you are seeking treatment for opioid use, this trial may help you find the most effective option.
This study tests a faster way to start buprenorphine (a medication for opioid use disorder) by using naloxone to briefly trigger mild withdrawal. This could help people get started on treatment more comfortably and quickly.
This study compares two methods of starting buprenorphine (a medication that helps reduce opioid cravings and withdrawal) for people who use fentanyl daily. The goal is to see which method helps people stay in treatment longer.
This trial tests whether starting buprenorphine using a low-dose plan is a safe and workable way to treat opioid use disorder. You may be able to join if you are 18+, have opioid use disorder, and can follow the study medication and visits.
This study tests a new way to receive buprenorphine—a once-a-month injection—from a mobile clinic that comes to you. It aims to make treatment more convenient and acceptable for people with opioid use disorder.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.